Evaluation of Pharmacokinetics, Safety and Tolerability of a Single Dose of Prucalopride, in Subjects With Moderate and Severe Hepatic Impairment, in Comparison With Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 18 Apr 2012
At a glance
- Drugs Prucalopride (Primary)
- Indications Constipation; Postoperative ileus
- Focus Pharmacokinetics
- Sponsors Shire-Movetis NV
- 18 Apr 2012 Actual end date changed from 1 Apr 2011 to 1 Feb 2011 as reported by ClinicalTrials.gov.
- 18 Apr 2012 Actual initiation date changed from 2 Jun 2010 to 1 May 2010 as reported by ClinicalTrials.gov.
- 11 Apr 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.